HOUSTON, June 15, 2005 (PRIMEZONE) -- Labwire Inc. (Pink Sheets:LBWR) announces that Dexter Morris, President of Labwire Inc., has been invited to present American private sector solutions and protocols at the European Workplace Drug Testing Society's 4th Symposium on Workplace Drug Testing to be held on June 16 - 17, 2005 in Dublin, Ireland with attendees from throughout Europe, South America and Asia.
The European Workplace Drug Testing Society (EWTDS) aims to ensure that workplace drug testing in Europe is performed to a defined quality standard and in a legally defensible way. Mr. Morris is set to lead an instructional session on the first day of the Symposium titled, "Mandatory Drug Testing: Why it Works for Greyhound," referring to the Company's contract with Laidlaw International, Inc., the parent company of Greyhound Lines, Inc., to provide comprehensive Employment Management and Drug Screening services.
"Labwire's mission is to become the leading national and international provider of Employment Management Screening services. The 4th Symposium on Workplace Drug Testing will address current issues and concerns facing workplace drug testing in Europe. I look forward to the opportunity to speak about my experiences working with large Fortune 500 clients implementing screening policies and protocols as well as to discuss the leading edge Labwire platform and its potential to raise the industry standard," commented Dexter Morris, President of Labwire Inc.
Dexter Morris has been involved in the Drug Testing Industry since its inception and was one of the founding members of SAPAA (Substance Abuse Program Administrators Association) in 1989. Mr. Morris also founded DISA (Drug Intervention Services of America) which was one of the industries top TPA's (Third Party Administrator). Recently, Mr. Morris has served as the U.S. Representative to the First International Symposium on Workplace Drug Testing held in Brazil which began to set international standards and credentials for drug testing worldwide. He currently serves as the Chairman of the nonprofit International Organization for Drugfree Workplaces (IODW).
Additional speakers at the Symposium include Chairman of the National Advisory Committee on Drugs, Des Corrigan, who is speaking about "Drug Impairment in the Workforce" and Donna Bush, PhD, Chief of Drug Testing for SAMSHA, who will present "New SAMHSA Guidelines." Some other topics that will be covered at the Symposium are "EU Perspective on Drug & Driving," "Role of Occupational Health in WDT," and "Testing Provisions of the New Health & Safety Act."
About Labwire, Inc.
Labwire Inc., Headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations. The Company offers a comprehensive set of solutions to manage all aspects of employee screening services including drug testing program development and policy analysis, medical review services, supervisor training and secure real-time online data management via the Labwire(tm) Platform. Labwire(tm) is a proprietary, real-time web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results.
For corporate and product information, please visit www.labwire.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.